I. Brunetti

Phase III Trial of Infusional Fluorouracil, Leucovorin, Oxaliplatin, and Irinotecan (FOLFOXIRI) Compared With Infusional Fluorouracil, Leucovorin, and Irinotecan (FOLFIRI) As First-Line Treatment for Metastatic Colorectal Cancer: The Gruppo Oncologico Nord Ovest

Alfredo Falcone, Sergio Ricci, I. Brunetti et al. · Journal of Clinical Oncology · 2007 · 1.2K citations · Full text

Long-Term Outcome of Initially Unresectable Metastatic Colorectal Cancer Patients Treated with 5-Fluorouracil/Leucovorin, Oxaliplatin, and Irinotecan (FOLFOXIRI) Followed by Radical Surgery of Metastases

Gianluca Masi, Fotios Loupakis, Luca Emanuele Pollina et al. · Annals of Surgery · 2009 · 234 citations

FOLFOXIRI plus bevacizumab as first-line treatment in BRAF mutant metastatic colorectal cancer

Fotios Loupakis, Chiara Cremolini, Lisa Salvatore et al. · European Journal of Cancer · 2013 · 185 citations

Gastrointestinal Oncology, Medicine, Pharmacology +7

Treatment with 5-Fluorouracil/Folinic Acid, Oxaliplatin, and Irinotecan Enables Surgical Resection of Metastases in Patients With Initially Unresectable Metastatic Colorectal Cancer

Gianluca Masi, Samanta Cupini, Lorenzo Marcucci et al. · Annals of Surgical Oncology · 2005 · 162 citations

Surgical Oncology, 5-Fluorouracil/folinic Acid, Colorectal Surgery +6

Biweekly Chemotherapy With Oxaliplatin, Irinotecan, Infusional Fluorouracil, and Leucovorin: A Pilot Study in Patients With Metastatic Colorectal Cancer

Alfredo Falcone, Gianluca Masi, Giacomo Allegrini et al. · Journal of Clinical Oncology · 2002 · 156 citations · Full text